Your cart:$ 0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Ezetimibe - Vytorin, Zetia

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Vytorin

Generic Vytorin

Simvastatin Ezetimibe 10mg + 10/20mg + 10mg

Generic Vytorin is used for treating high cholesterol along with a cholesterol-lowering diet. It works by reducing the amount of cholesterol that your body absorbs from your meals. Lowering cholesterol levels in the blood reduces the chance of heart disease, heart attacks and strokes.

More info »
$ 1.97 Buy now!
Zetia

Generic Zetia

Ezetimibe 10mg

Generic Zetia is used for treating high blood cholesterol along with a low-fat, low-cholesterol diet. It may be used alone or with other medicines. It is also used to treat high blood sitosterol and campesterol along with diet therapy.

More info »
$ 1.17 Buy now!
Country, language and currency
Social bookmarks:
Testimonials
I,HAVE RECEIVED THE PRODUCT. I tested it out and my date was tottally satisfied.She wants to get together now twice a week instead of only once.thank you for a life changing product.I ALLREADY enjoy my life but to bring joy to her is a great gift.plus with the dollars we save we can afford to go out. - satisfied customer stewart
Read more »

Our billing is certified by:

Secure shopping certificates


Special Offer!

Merck Wins U.S. ZETIA(R) (ezetimibe)/ VYTORIN(R) (ezetimibe/simvastatin ... - MarketWatch (press release)
Merck Wins U
Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks; - FiercePharma
Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks;FiercePharmaArticle | Follow @FiercePharma > A US court upheld Merck's ($MRK) patent on the active ingredient ezetimibe, marketed as the cholesterol-lowering Zetia and in the combo cholesterol pill Vytorin
Investor Medical Waves - (VVUS, MRK, MYL, AMPE) - Galaxy Stocks
Investor Medical Waves - (VVUS, MRK, MYL, AMPE)Galaxy StocksInc
Advanced Atherosclerosis: The Heart and Beyond - Medscape
Advanced Atherosclerosis: The Heart and BeyondMedscapeThe premise of AIM-HIGH was to see if adding extended-release niacin to raise HDL cholesterol in patients who had already achieved a very low LDL cholesterol level (40 to 80 mg/dL) with simvastatin (and ezetimibe if needed) would lead to further risk
Toward Regenerative Medicine Against Atherosclerosis cardiovascular disease - Next Big Future
Toward Regenerative Medicine Against Atherosclerosis cardiovascular diseaseNext Big FutureOnce-promizing agents such as ezetimibe, niacin, ApoA-1 Milano, and torcetrapib have either been found to provide no benefit, or evento increase mortality rates
bookmark Bookmark this site
Subscribe to the News